Pieter Cullis
For their pioneering work developing nucleoside-modified mRNA and lipid nanoparticle (LNP) drug delivery: the foundational technologies for the highly effective COVID-19 mRNA vaccines.
Afiliado al momento del premio
Universidad de Columbia Británica
Vancouver, Canadá